Search Results 731-740 of 17703 for Substance+dependence

  1. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

    The purpose of this research study is to determine the maximum tolerated dose and safety of three drug combinations. ... Has known psychiatric or substance abuse ...

  2. Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto (Sacubitril/Valsartan) in Heart Failure - Mayo Clinic

    Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto (Sacubitril/Valsartan) in Heart Failure · More about research at Mayo ...

  3. Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) (ReLATE) - Mayo Clinic

    Have current drug or alcohol abuse or dependence, or a history of drug or alcohol abuse or dependence within 364 days prior to Baseline; Pregnant or ...

  4. Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE) - Mayo Clinic

    Alcohol dependence (i.e., a score > 8 on the Alcohol Use Disorders Identification Test) 5. Narcotics or any other drug abuse or dependence in the last 5 years

  5. Drug allergy - Doctors and departments - Mayo Clinic

    Learn which medicines are more likely to cause an allergic reaction, what symptoms look like and what treatments can calm such a reaction.

  6. Transformative Research In Diabetic Nephropathy - Mayo Clinic

    By condition, treatment or drug name. Search tips. Transformative ... History of active alcohol and/or substance abuse that in the investigator's ...

  7. Psychiatry and Psychology - Overview - Mayo Clinic

    Integrated care · Services · Inpatient psychiatric units (Minnesota only) · Mayo Clinic Depression Center · Pain Rehabilitation Center · Addiction Treatment Center.

  8. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

    A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung ...

  9. Ketamine for Depression and Suicide Risk - Mayo Clinic

    ... dependence of drugs and alcohol only in full remission (> 1 month, < 12 months). Patients will be allowed to enroll if their drug and alcohol abuse / dependence ...

  10. Somatic symptom disorder - Diagnosis and treatment - Mayo Clinic

    Have you fill out forms or answer questions to learn about your anxiety, mood and physical symptoms. Ask you about alcohol, drug or other substance use. A ...